Market Cap (In USD)
7.04 Million
Revenue (In USD)
5.44 Million
Net Income (In USD)
-14.09 Million
Avg. Volume
508.86 Thousand
- Currency
- USD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.3339-5.39
- PE
- -
- EPS
- -
- Beta Value
- 0.5707383
- ISIN
- US49461C1027
- CUSIP
- 49461C102
- CIK
- 1445283
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Mr. Craig W. Philips
- Employee Count
- -
- Website
- https://kinetabio.com
- Ipo Date
- 2016-02-11
- Details
- Kineta, Inc., a clinical stage biotechnology company, develops immunotherapies for oncology, neuroscience, and biodefense. It serves private, government, and industry partners. The company has strategic partnerships with Pfizer, Genentech, Wellcome, and Samsung Biologics Co., Ltd. Kineta, Inc. was formerly known as Lecura, Inc. The company was incorporated in 2007 and is based in Seattle, Washington.
More Stocks
-
300985
-
603638
-
ISLCONSULISL Consulting Limited
ISLCONSUL
-
PAT
-
PSL
-
LE
-
PKTEA
-
028260Samsung C&T Corporation
028260